Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
Isocitrate dehydrogenase (IDH)-mutant astrocytomas with homozygous deletion of cyclin-dependent kinase 2A/B (CDKN2A/B-HomoD) are categorized to grade 4 in the new World Health Organization (WHO) classification. However, the clinical implications of CDKN2A/B-HomoD in oligodendrogliomas remain unclear...
Saved in:
| Main Authors: | Satoshi NAKASU, Shoichi DEGUCHI, Yoko NAKASU |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Japan Neurosurgical Society
2024-12-01
|
| Series: | Neurologia Medico-Chirurgica |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/nmc/64/12/64_2024-0105/_pdf/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort
by: Thibaut Wolf, et al.
Published: (2025-08-01) -
Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas
by: Jing Bao, et al.
Published: (2025-05-01) -
A systematic literature review of MTAP deletions in solid and hematologic Cancers
by: Mary C. Clouser, et al.
Published: (2025-01-01) -
Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01) -
Association of CDKN2A/B deletions with survival of patients with diffuse large B-cell lymphoma
by: M. V. Sarpova, et al.
Published: (2024-01-01)